https://www.linkedin.com/posts/polarean-inc-_xenonmri-pulmonaryhypertension-ph-activity-7318636449455636480-rmtA?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0c |
I know which method I'd prefer, and allows for risk free repeat analysis -https://www.linkedin.com/posts/american-association-of-physicists-in-medicine_press-release-aapm-addresses-concerns-from-activity-7318242292106989568-utjH?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0c |
A T/o being worked as sure eggs are eggs. Gla |
Just hold 👍🤞 |
Though its not clear what is behind that prediction! |
That's bold washingmachine. I obviously hope that happens for all of us who have kept the faith! |
8 -- 10 p to be precise ! |
My target price here is 10 pence Before Xmas 25 Hope this calms your persistence or anxiety towards what's happening here. |
that would be really tough to do for one to two years! |
Hold tight 😎 |
washingmachine, any update on the 'big news' that your reliable source said was imminent? |
Goldbutler don't take it so personally, sell buy or move on.You're so duplicitous when the next impending news appears you will be vociferous in saying this is the greatest company on earth. |
Polarean CEO's have done interviews with Vox Markets
and Paul HILL has interviewed fund and asset managers there over the last 3 months
such as
Downing ,Rathbones ,Gresham House , Premier Miton ,Stellar ,Harwood capital ,Amati
and Octupus uk.
They all pick 20 to 25 shares to talk about and not one of them talks Polarean
even Rathbones and Amati.
The brokers to Polarean and the Board of Directors with chairman WEST
and Von Jacko have soured the Aim investors by their greed in fleecing the company of cash and repricing options for their sole benefit. AND FEW SALES.
Nukem and Bracco including director Petit should be ashamed of themselves:
the sheer stupidity of their greed and incompetence in failing to deliver any meaningful return to shareholders or potential shareholders after sucking almost £40 million from Aim has resulted in them being shunned by the market.
Nukem and Bracco don't own the patents and Polarean is only on licence from GEC healthcare. They might just end up with nothing. |
On 24 December 2019 RNS 9061x
Polarean stated that the total number of the company's Polarisers either installed or on order remains 25.
On 27 February 2025 trading update Polarean stated " the Company has 22 Xenon MRI platform customers, seven sites of which have either received or pending clinical hyperpolariser systems.
In the years between 2019 and 2025 Polarean directors have
SUCKED fees, salaries, bonuses, in the form of cash and options from the company
and have repriced options under Chairman WEST and Von Jacko.
It has taken 3 years for them to look outside the USA for a sale.
The mystery sale remains a mystery and they have sold one in ALABAMA.
The CEO and Chairman and Board of Directors should have the courage to hold an AGM in the UK. |
Not very independent Non-exec directors at Polarean
have not been looking after AIM shareholders.
The sheer quantity of options and fees and bonuses and salaries
have sorted them out.
Bracco and Nukem must be delighted - with 33% of the company
.
They couldn't care less about AIM or any shareholders or prospective shareholders |
Sounds good......https://www.linkedin.com/posts/erinangel_pediatriccare-builtforkids-futureofhealthcare-activity-7316122109305360384-hG0h?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0c |
Now signalled buy on british bulls |
One piece of news and this is back to the 1.5p mark in an heartbeat. Great news or a series and we break 2p finally. Things will transform here. Feels very pent up and a buy in price at placing. And below 0.09 for the ballsy like myself.Do not miss the boat. And the Trump bonus |
Always advancing, the benefits are apparent to partners. https://www.linkedin.com/posts/polarean-inc-_xenonmri-longcovid-lunghealth-activity-7315803447818113025-Y11D?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0c |
Non dilutive funding is key to success here - check with your source whether that’s on the cards here. It’s needed soon to find gas exchange trial |
That's a likely road. Cvj has sold companies in the past. The things petit at bracco been saying on LinkedIn suggests that partnership only gets stronger and more of an appetite just to buy out. On the board, large shareholder, and eventual acquirer is a pattern I've seen before and been involved in within medtech. Fda expansion overdue and likely any day. News on gas exchange progress due too. That may be alongside the non dilutive jv partner. |
Was hoping the big news was about a non dilutive source of funding. |
They'll all land when they land.Patience is the key as usual. Especially from this level. 12 months of cash runway. And medical budgets in the U.S. only get going may onwards. The other news items aren't budget related. |
moon, are you in the know? oh go on, give us a clue and also when its due to land. |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
